Provider review
Prime Doctor RX review: it publishes no weight-loss figure at all, and that is the finding
We grade sellers on whether their claims survive the trials. Prime Doctor RX barely makes any. There's no weight-loss percentage anywhere on the site, no pounds figure, no timeline, no satisfaction rate, no patient count and no before-and-after photograph. What's there instead is a run of sentences declining to promise: treatment only when clinically appropriate, no treatment guaranteed, a clinician makes the call. That's the opposite of the usual failure here, and worth saying plainly. It also isn't the same thing as being well-evidenced — saying nothing isn't proving anything.
Some links on this site are affiliate links, and we may earn a commission. How we’re paid
Visit Prime Doctor RXOf Prime Doctor RX’s 3 dated product claims documented below, 3 are consistent with the cited evidence. Among the dated prices documented below, the lowest listed upfront charge is $249 for 28 days (Compounded semaglutide injection, charged every 28 days). A matching claim does not mean the compounded product was tested or FDA-approved.
Makes no outcome claim at all, which means it makes none the trials can contradict — and none it has shown either.
Worth trusting if
- You want a seller that tells you a clinician decides, rather than telling you it will work
- You want every price visible before you answer a single question
- You are tired of unsourced patient counts and before-and-after photographs
Be skeptical if
- You want a seller to show you what its own patients achieved, because this one publishes nothing
- You want to know which pharmacy makes your medication
- You want to know which company you are contracting with
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Compounded
Phase 3 trials
Not confirmed
None found
Provenance
Products reviewed at Prime Doctor RX
These evidence cards classify the treatments evaluated in this review. Confirm the exact medicine and formulation proposed for your prescription with the care team.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — $249 charged every four weeks, which is thirteen times a year rather than twelve.
- Compounded tirzepatide injection — $339 every four weeks, the dearest of the three weight-loss products.
- Compounded oral semaglutide tablet — $279 every four weeks — dearer than the injection, with no reason given.
Evidence
Has the molecule been tested for what it is sold for?
Each row summarizes human evidence for the molecule and the use being advertised. Results apply to the product, dose, population and outcome studied; they do not establish that this provider’s preparation or program produces the same results. Compounded drugs are not FDA-approved. Evidence for one use should not be assumed to support another.
3
Products with human evidence
For the advertised use, out of 3 products reviewed here. The evidence concerns the molecule, not Prime Doctor RX's service.
2
Registry records cited
Distinct ClinicalTrials.gov records cited across the reviewed products. Registration alone does not establish that a treatment works.
The comparison
What they claim, against what the trials show
Each claim below is quoted word for word from Prime Doctor RX’s own page. Tap a row to see the quote, the trials behind it, and why it got that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“Personalized GLP-1 care with semaglutide injection when clinically appropriate. For eligible men and women. Clinician-guided treatment decision. Labs ordered when clinically appropriate. No treatment guaranteed.”
Read on the Prime Doctor RX site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, mean weight reduction of about 15% on semaglutide 2.4 mg. Listed here as the evidence base for the molecule, not because Prime Doctor RX cites it — the site cites no trial anywhere.
There is nothing here to exceed the trials, because there is nothing here. Prime Doctor RX describes what the medication is and who decides whether you get it, and never says what it will do to your weight. No percentage, no pounds, no timeline, no success rate. The sentence doing the most work on the page is "medication is never guaranteed just because you complete an intake", which is a refusal rather than a promise. Read that as the absence of a false claim rather than the presence of a true one: the company has not shown anything about its own product, and it cites no trial at all, including the one listed above.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“Personalized GLP-1/GIP care with tirzepatide injection when clinically appropriate. Eligibility reviewed by a licensed clinician. Ongoing follow-up and refill review. Treatment only when clinically appropriate.”
Read on the Prime Doctor RX site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly. Again, listed as the molecule's evidence base rather than as a citation Prime Doctor RX makes.
The only substantive claim on this product is mechanistic — that tirzepatide acts on two hormone receptors — and that is an accurate description of the molecule rather than a promise about a result. No weight-loss figure, timeline or comparison against semaglutide appears anywhere on the page. The same caveat applies as to every compounded product on this site: SURMOUNT-1 tested the manufacturer's approved tirzepatide, not a compounded preparation, and no trial has compared the two.2
Compounded oral semaglutide tabletSemaglutide · Compounded (503A)Claim matches the trials
“A non-injection semaglutide option for eligible patients when clinically appropriate. Clinician review required. No treatment guaranteed.”
Read on the Prime Doctor RX site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. Tested semaglutide as a once-weekly injection at 2.4 mg. It is not a trial of a daily compounded tablet, and it establishes no dose equivalence between the two forms.
Prime Doctor RX sells the tablet as an option for people who would rather not inject, and claims nothing else for it — no equivalence to the injection, no weight-loss figure, no timeline. That restraint is the right call, because no trial cited anywhere supports a compounded daily tablet doing what a weekly injection does. It is also the most expensive of the three products per cycle, which the site does not explain.1
Dispensing chain
Who actually fills your prescription
Read the full account
No pharmacy is named. The Terms describe the arrangement at the level of a category — medication fulfillment may be handled by licensed pharmacies or other third-party fulfillment providers — and name nobody. The homepage, the Terms and the privacy policy name no pharmacy, no compounding tier and nobody the drug is compounded by. The prescribing side is described the same way, as a licensed clinician, with no individual, medical director or advisory panel named. What the site does say, and says repeatedly, is that a clinician decides whether treatment happens at all.
Read on the Prime Doctor RX site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Not established in this source review
Certificate of analysis readable
A readable lot report was not verified here
Read the full testing account
No certificate of analysis, potency, purity or sterility result appears anywhere on the site — and neither does any of the marketing that usually stands in for one. There is no patient count, no satisfaction figure, no testimonial, no before-and-after photograph and no review score. That is unusual enough to be worth stating, because the absence of unsourced social proof is itself a kind of restraint. It leaves a reader with nothing to check and nothing to be misled by, in that order.
Read on the Prime Doctor RX site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
The October homepage separates hormone care from weight-loss eligibility. Its hormone protocol has treatment-specific state and age restrictions, including no service under that protocol in Louisiana. Medical weight-loss availability is confirmed separately during intake; do not apply the hormone list to every product.
Read the full licensing claim
The current homepage identifies OpenLoop Healthcare Partners, PC, as the clinical provider group. This does not identify the individual clinician assigned to a patient or the dispensing pharmacy.
Read on the Prime Doctor RX site, October 2026.
Regulatory
The FDA warning letter
No FDA warning letter found
Assessment
What holds up, and what does not
- It publishes no weight-loss percentage, no timeline and no success rate, so it overstates nothing.
- "Medication is never guaranteed just because you complete an intake" appears in the body copy, not the small print.
- "Treatment only when clinically appropriate" is attached to every product rather than stated once.
Show 4 more
- There are no testimonials, no before-and-after photographs and no patient count to be misled by.
- Its description of tirzepatide acting on two hormone receptors is accurate and promises nothing.
- It says plainly that labs may be required, rather than implying treatment is automatic.
- No FDA warning letter.
- It cites no trial anywhere, so nothing on the site connects its products to published evidence.
- No pharmacy is named, and nothing says whether the medication is made to order or dispensed ready-made.
- No company is named in fifteen sections of terms — no business name, no address, no state.
Show 4 more
- No clinician is named — not a prescriber, not a medical director, not an advisory panel.
- The daily tablet is the dearest product per cycle, and the site never says why.
- Its hormone add-ons are listed without product pages, so what is being sold is unclear.
- Every price says "/mo" and is charged every 28 days, which is thirteen charges a year.
Verdict
The bottom line
Restraint is the whole story here, and it cuts both ways. Nothing on this site will mislead you about what a GLP-1 does, because nothing on it says. That is genuinely better than the alternative, and it is not the same as evidence — the trials behind these molecules are strong, and Prime Doctor RX neither cites them nor adds anything to them. Ask who fills the prescription and which company you are paying before you order.
Opens Prime Doctor RX's website. A link is not a recommendation to take anything.
The longevity products are add-ons
The October 13 homepage describes NAD+ and sermorelin as possible additions after its hormone-care evaluation, not standalone programs. That makes the cost and requirements of the underlying hormone service part of the buying decision. It says refunds can be requested except for a month in which medication has already been ordered. 3
For the GLP-1 plans, distinguish the lower prepaid headline from the explicitly listed four-week recurring option. Ask for the total upfront amount, how many weeks it covers and the cancellation cutoff before an order is sent to the pharmacy. The older price captures below are not a fresh quote. The current footer names OpenLoop Healthcare Partners, PC, for medical services. Its hormone-state restrictions do not establish GLP-1 availability, which is confirmed separately during intake.
Full analysis — 4 more sectionsThe finding is what isn't there · Why that matters here · And the limit of that · The question it won't answer
The finding is what isn't there
Look for the usual things on Prime Doctor RX's homepage, Terms and privacy policy: a weight-loss percentage, a pounds figure, a timeline, a satisfaction rate, a patient count, a before-and-after.
None of them exists.
What's there instead reads like a series of refusals:
"GLP-1 options, when appropriate."
"…available for eligible men and women after clinician review."
"Treatment only when clinically appropriate."
"No treatment guaranteed."
"Medication is never guaranteed just because you complete an intake."
"A clinician makes the call."
Why that matters here
This site grades whether a seller's claims survive the trials. Most failures come from a seller reaching past the evidence — a maintenance rate no trial supports, a trial result placed a year early, a success probability of 100% on a screen a clinician never saw.
Prime Doctor RX doesn't reach, because it doesn't claim. There is nothing on it for STEP 1 1 or SURMOUNT-1 2 to contradict.
And the limit of that
Saying nothing isn't proving anything.
Prime Doctor RX cites no trial at all. The two listed on this page are ours, not theirs — the evidence base for the molecules, included so you can see what the drugs have actually been shown to do. The company has published nothing about its own product, its own patients or its own outcomes.
There's also the caveat that applies to nearly every seller here: both trials tested the manufacturers' approved medicines. Prime Doctor RX sells compounded versions, made to order by a pharmacy, not FDA-approved, and never compared with the approved product in a trial.
The question it won't answer
One thing genuinely missing rather than admirably absent: who makes your medication.
The Terms say only that fulfillment "may be handled by licensed pharmacies or other third-party fulfillment providers". No pharmacy name. No address. Nothing about whether the drug is made to order under your prescription or dispensed ready-made.
Fifteen numbered sections of Terms, a Texas choice-of-law clause, and no company named either. A site this careful about not overpromising is oddly quiet about who is doing the promising.
Questions
Frequently asked questions
How much weight will I lose with Prime Doctor RX?
The site doesn't say, anywhere. There's no percentage, no pounds figure and no timeline on the homepage, the terms or the privacy policy. That's unusual and, on balance, better than a number with no trial behind it — but it does mean you'd be going in with nothing from them to set expectations against.
Does it cite any clinical evidence?
No. Prime Doctor RX names no trial, no journal and no study anywhere on the site. The trials referenced on this page are ours, included so you can see what these molecules have been shown to do in published research.
Is "no treatment guaranteed" a warning sign?
The opposite, in our view. It's an accurate description of how prescribing is supposed to work, and it appears in the body copy rather than buried in the terms. Sellers that promise approval before a clinician has looked are the ones worth worrying about.
Do the trials apply to what this company sells?
Partly. STEP 1 and SURMOUNT-1 tested the manufacturers' approved semaglutide and tirzepatide. Prime Doctor RX sells compounded versions, which are made to order by a pharmacy, are not FDA-approved, and have never been compared with the approved product in a trial.
Who makes the medication?
Not stated. The terms mention licensed pharmacies and third-party fulfillment providers as a category and name none of them, and nothing says whether the medication is made to order or dispensed ready-made. Neither a compounding tier nor a pharmacy name appears on the homepage, in the Terms or in the privacy policy.
Glossary
Key terms
Show definitions
- Compounded
- Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
- STEP 1
- The phase 3 trial of once-weekly semaglutide 2.4 mg for weight loss — 1,961 adults over 68 weeks, published in the New England Journal of Medicine in 2021.
- SURMOUNT-1
- The phase 3 trial of once-weekly tirzepatide for weight loss — 2,539 adults over 72 weeks at 5, 10 and 15 mg, published in the New England Journal of Medicine in 2022.
Compare
Others selling what Prime Doctor RX sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Ranked
The lists Prime Doctor RX is on
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Prime Doctor RX's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 3 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, mean weight reduction of about 15%. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks at 5, 10 and 15 mg once weekly. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
- Publisher (2026). Public buyer information checked October 13, 2026. Public primary source. the Prime Doctor RX site
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.